173 research outputs found
Implementing Regulation 2019/947/EU on the rules and procedures for Drones
No full textThe European Commission has recently adopted Implementing Regulation 2019/947/ EU (hereinafter "Drone OPS Regulation") which will apply from 1st July 2020. It intro- duces new common EU technical standards and related administrative procedures for the operation of unmanned aircraft
New Regulation Safeguarding Competition in Air Transport
No full textThe European Council adopted a new Regulation (n. 712/2019) to safeguard the competitiveness of EU air carriers against unfair competition and other practise implemented by non-EU airlines. The new legislation has entered into force in May 2019 and goes beyond the existing Regulation n. 868/2004, which has proved to be ineffective because, under the old Regulation, a legitimate complaint could be filed by the European air carriers whose collective share constitutes a major proportion of the total Community supply of those services
International regulation of non-military drones
No full textThe increasing civilian use of Unmanned Aircraft Systems (UASs) is not yet associated with a comprehensive
regulatory framework, however new rules are rapidly emerging which aim to address this shortfall. This book
offers a thorough examination of the most up-to-date developments, and considers potential ways to address
the various concerns surrounding the use of UASs in relation to safety, security, privacy and liability
Le Memorie, archivio aperto
No full textIl contributo delinea il percorso di ricerca seguito dall'autore relativo all'edizione digitale del lavoro a stampa: Memorie su le antiche case di Udine di Giovanni Battista della Porta, a cura di Vittoria Masutti (1984-1987) | The paper describes the research work carried out by the author, concerning the digital edition of the volume Memorie su le antiche case di Udine di Giovanni Battista della Porta, edited by Vittoria Masutti (1984-1987
Hoplocampa chamaemespili Masutti & Covassi 1980
No full text<i>Hoplocampa chamaemespili</i> MASUTTI & COVASSI, 1980 M a t e r i a l: 1♀ 1♂ A., Kärnten, Dobratsch, Schütter Wald, 700-900m, N 46.34.57 E13.44.23, <p>6.5.1998, leg. A.W. Ebmer, in coll. et det. W. Schedl 2013. Neu für Österreich (siehe SCHEDL 2017).</p> <p> B e m e r k u n g: Die Larven leben in Früchten von <i>Sorbus chamaemespilus</i> (L.), die Imagines können als Blütenbesucher an den Blüten der Wirtspflanze beobachtet werden! Erst 2019 fand der Verfasser unter seinem undeterminierten Material 1♂ von N-Tirol, Kaisertal, Bettlersteig, 1200m, 11.6.(19)75, leg. W. Schedl, det. 2019. Das ist der erste Nachweis der Art südlich des Alpenhauptkammes!</p>Published as part of <i>Schedl, Wolfgang, 2019, Beitrag zur Symphyta-Fauna des Naturparks Villacher Alpe (Dobratsch) im Kärntner Gailtal (Insecta, Hymenoptera), pp. 1185-1193 in Linzer biologische Beiträge 51 (2)</i> on page 1191, DOI: <a href="http://zenodo.org/record/3742118">10.5281/zenodo.3742118</a>
Ground Testing Investigation of Hypersonic Transition Phenomena for a Re-Entry Vehicle
No full textAerodynamics, Wind Energy & PropulsionAerospace Engineerin
The importance of transaminases flare in liver elastography: Characterization of the probability of liver fibrosis overestimation by hepatitis C virus-induced cytolysis
Get PDFBackground: Liver stiffness measurement (LSM) is crucial for appropriate fibrosis staging in patients with ongoing hepatitis C virus (HCV) infection. However, there is still an ongoing debate on the impact of serum transaminases (aspartate-aminotransferase, AST; alanine-aminotransferase, ALT) on LSM. Methods: We selected 110 patients undergoing HCV eradication therapy with LSM compatible with significant liver fibrosis. LSM was evaluated prior to therapy and one year after HCV eradication. Results: LSM showed a median decrease of 35% from baseline values, and 67 (61%) patients showed posttreatment values compatible with lower fibrosis stages. We developed two logistic regression models to determine the probability of liver fibrosis overestimation according to serum transaminase. The probability of overestimation of two or more fibrosis grade is equal to (1) 50% for AST of 99 IU/L (2.2 ULN) and ALT of 90.5 IU/L (2 ULN), (2) 80% for AST of 123.5 IU/L (2.74 ULN) and ALT of 101.5 IU/L (2.25 ULN), and (3) reaches 100% for AST of 211 IU/L (4.7 ULN) and ALT of 140 IU/L (3.1 ULN). Conclusions: This study highlights the impact of serum transaminases on LSM. We believe that our findings may serve as a reference point for appropriate fibrosis stratification by liver elastography in patients with HCV infection
Incidence and natural course of fatty liver in the general population: The Dionysos study
No full textAbstract: Using the general population of the Dionysos Study, we followed up 144 subjects without fatty liver (FL-) and 336 with fatty liver (FL+) for a median time of 8.5 years. All subjects had suspected liver disease (SLD) defined as altered liver enzymes, high mean corpuscular volume, or low platelet count in the absence of HBV and HCV infection. Ethanol intake was assessed using a food frequency questionnaire, and FL was diagnosed using ultrasonography. The incidence and remission rates of FL were 18.5 and 55.0 per 1,000 person-years. Progression to cirrhosis or HCC was rare in both cohorts (incidence rate: 1.7 versus 1.1 and 0.8 versus 0.4 per 1,000 person-years for FL- versus FL+). Multivariable Poisson regression was performed to identify predictors of FL incidence and remission among sex, age, body mass index, ethanol, and liver enzymes. Every increase of 20 g/day of ethanol intake at baseline was associated with a 17% increase in the rate of incident FL (P = 0.019), a 10% decrease in the rate of remitting FL and SLD (P = 0.043), a 19% decrease in the rate of remitting FL with persistent SLD (P = 0.002), and a 10% increase in mortality rate (P = 0.005) in the FL+ cohort. Conclusion: In the general population of the Dionysos Study, FL regressed in nearly I of every 2 cases and had a substantially benign course. Ethanol intake was the most important risk factor for FL remission and incidence and a predictor of mortality in subjects with FL
- …
